ClinicalTrials.Veeva

Menu

Impact of HPV on a Cohort of Southern Italian Women: Epidemiological, Clinical, Morphological and Microbiological Features

U

University of Campania "Luigi Vanvitelli"

Status

Completed

Conditions

Cervix Cancer

Treatments

Diagnostic Test: Cervical biopsy

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

HPV is known to be the causal agent in the majority of cervical cancers. However, the role of the cervical bacterial microbiome in cervical cancer is not clear

Enrollment

150 patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Women in fertile age

Exclusion criteria

  • severe comorbidities

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

150 participants in 3 patient groups

HPV-positive patients
Active Comparator group
Description:
Patients who are positive for HPV DNA test
Treatment:
Diagnostic Test: Cervical biopsy
HPV-positive patients - Echinacea
Active Comparator group
Treatment:
Diagnostic Test: Cervical biopsy
HPV-positive patients - Standard
No Intervention group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems